The search for more effective therapies to treat diabetes is a growing need that concerns both specialist doctors and patients.

That said, researchers at the University of Alberta (Ualberta), Canada, have shown a possible new effect of an older antipsychotic drug.

According to this research published in the journal Diabetes, a certain type of these drugs it could lower blood sugar levels.

As explained in a note from Medical News Today, the effect would be due to its action against an enzyme related to hyperglycemia.

When treatment fails

The need for this option, following the note from Medical News Today, is due to the fact that many people with type 2 diabetes may not benefit from metformin, the main drug prescribed in these cases, or alternatives.

This lack of response would be associated with genetic and non-genetic factors. “These are patients who respond less to multiple drugs that improve blood sugar control by increasing insulin secretion”scientist John R. Ussher explained to Medical News Today.

“Developing new therapies is a key way to improve outcomes, which will also be associated with lifestyle changes,” added endocrinologist and diabetes specialist Dr. Jason Ng.

Why use already known drugs

The PhRMA Foundation explains that developing a new drug takes an average of ten years and the process is very expensive.

With which, indicates the note Medical News Today, expanding the use of an existing drug is faster and easier. Since clinical trials and other initial tests have already been passed.

What is type 2 diabetes

Type 2 diabetes is the disease in which glucose or blood sugar levels are too high.

The body doesn’t make enough insulin or doesn’t use it well. Hence, glucose remains in the blood and does not enter cells enough to provide energy for the body to carry out its functions.

Being overweight or obese, not doing physical activity and family history are factors that predispose to its appearance.

With proper medical follow-up and treatment, type 2 diabetes can be controlled.